PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
[11]   PHASE-II STUDY OF MAYTANSINE IN THE TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
THIGPEN, JT ;
EHRLICH, CE ;
CONROY, J ;
BLESSING, JA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04) :427-430
[12]   PHASE-II TRIAL OF PIPERAZINEDIONE IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
THIGPEN, JT ;
BLESSING, JA ;
HOMESLEY, HD ;
PETTY, W .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01) :21-23
[13]   PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SLAYTON, RE ;
BLESSING, JA ;
STEHMAN, FB ;
MALFETANO, J .
CANCER TREATMENT REPORTS, 1986, 70 (09) :1127-1128
[14]   PHASE-II TRIAL OF CISPLATIN IN ADVANCED OR RECURRENT CANCER OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
THIGPEN, JT ;
BLESSING, JA ;
HOMESLEY, HD ;
BEREK, JS ;
CREASMAN, WT .
GYNECOLOGIC ONCOLOGY, 1986, 23 (01) :101-104
[15]   Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group [J].
Mannel, RS ;
Blessing, JA ;
Boike, G .
GYNECOLOGIC ONCOLOGY, 2000, 79 (01) :64-66
[16]   PHASE-II STUDY OF VINBLASTINE IN PREVIOUSLY TREATED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SUTTON, GP ;
BLESSING, JA ;
BARNES, W ;
BALL, H .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06) :470-471
[17]   PHASE-II TRIAL OF ADRIAMYCIN IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
THIGPEN, JT ;
BUCHSBAUM, HJ ;
MANGAN, C ;
BLESSING, JA .
CANCER TREATMENT REPORTS, 1979, 63 (01) :21-27
[18]   A PHASE-II TRIAL OF GALLIUM NITRATE (NSC-15200) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
MALFETANO, JH ;
BLESSING, JA ;
HOMESLEY, HD ;
HANJANI, P .
INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) :109-111
[19]   Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study [J].
Rose, PG ;
Blessing, JA ;
Buller, RE ;
Mannel, RS ;
Webster, KD .
GYNECOLOGIC ONCOLOGY, 2003, 89 (02) :267-270
[20]   PHASE-II STUDY OF ESORUBICIN (4'-DEOXYDOXORUBICIN) IN ADVANCED OR METASTATIC SQUAMOUS CARCINOMA OF THE UTERINE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
MCGUIRE, WP ;
BLESSING, JA ;
YORDAN, E ;
BEECHAM, J .
INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) :235-238
12345